StockData

Bioceres Crop Solutions vs Cibus

BIOX and CBUS side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BIOX and CBUS compare

Cibus grew revenue faster over the last twelve months (−10.3% versus −17.7% for Bioceres Crop Solutions).

Cibus scores higher on the StockData Score (4 against 1 for Bioceres Crop Solutions), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBIOXCBUS
Size and price
Market cap–$88.7M
Share price$0.233$1.16
Change, 1 year−86.6%−12.8%
Change, 5 years−98.5%−99.3%
Beta (5Y)0.761.74
Employees562118
StockData Score
Total score14 (better)
Valuation score00
Growth score01 (better)
Performance score01 (better)
Health score12 (better)
Dividend score00
Valuation
P/S–20.4×
P/B–6.0×
FCF yield–−52.2%
Fair value–$0.461
Margin of safety–−151%
Growth
Revenue growth (TTM)−17.7%−10.3% (better)
Revenue growth, 5Y average2.6% (better)−31.3%
Profitability
Gross margin34.9%–
Operating margin−9.8% (better)−1451%
Net margin–−2259%
FCF margin27.3% (better)−1066%
Return on equity–−226%
Return on invested capital−7.4% (better)−311%
Financial health
Debt / equity10.010.06 (better)
Interest coverage−0.6×–
Current ratio0.801.62 (better)
Altman Z-score–−4.46
Piotroski F-score–4
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions13.2%24.2%
Held by insiders73.3%35.2%
Short interest, % of float2.7%6.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.